Monitor whether Adage continues to reduce its position in future filings; a sustained decline by a notable institutional holder could signal reduced conviction, though the current passive filing alone is not a directional signal.
TENX drugs
TENX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 12 $1.61entry
- T+1 · 4d ago +0.62%α +0.98% · $1.62
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Adage Capital Management L.P. filed an amended Schedule 13G disclosing a 2.26% passive beneficial ownership stake in Tenax Therapeutics as of September 30, 2026, down from a prior filing. The stake includes 857,270 shares (447,537 of which are issuable upon exercise of warrants), representing a reduction in Adage's position. The filing reaffirms passive intent with no activist plans.
Key Financial Metrics
Key Facts
- Adage Capital Management L.P. disclosed a 2.26% passive beneficial ownership stake in Tenax Therapeutics as of September 30, 2026.
- The stake consists of 857,270 shares, including 447,537 shares issuable upon exercise of warrants.
- The filing is an amendment to a prior Schedule 13G, indicating a reduction in Adage's position.
- Adage reaffirms passive intent with no activist plans.
- The percentage is based on 37,423,917 shares outstanding as of July 28, 2026, assuming warrant exercise.
Financial Impact
Adage reduced its stake to 2.26% from a prior higher level; the exact prior percentage is not stated in this filing.
Risk Factors
- Adage's reduction may indicate waning institutional interest, but the filing confirms passive intent with no activist plans.
- The company's small market cap ($77M) makes it sensitive to any further institutional selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000919574-26-007573 |
| Document: 0000919574-26-007573-index.html | 0000919574-26-007573 |
| Document: 0000919574-26-007573.txt | 0000919574-26-007573 |
Track record
30 reports on TENX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.48 Now $1.48 +0.00% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 4/10 Entry $1.52 Now $1.48 −2.63% settles Dec 16
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $1.52 Now $1.48 +2.63% settles Dec 16
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $1.52 Now $1.48 +2.63% settles Dec 15
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $1.60 Now $1.48 −7.51% settles Dec 15
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $1.62 Now $1.48 +8.64% settles Dec 15
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Viewing Entry $1.61 Now $1.48 −8.07% settles Dec 11
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $1.63 Now $1.48 −9.20% settles Dec 4
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $1.88 Now $1.48 −21.28% settles Nov 25
- Oct 15, 20264w ago SC 13G/A Neutral 3/10 Entry $1.36 to $1.62 Now $1.48 +8.82% ▲ +19.12% +20.28% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers